Downstream Processing

Best before... Image: StanleyD

Cell Therapy Manufacturing & Gene Therapy Congress - Brussels, Belgium

Short shelf-life poses problems for cell therapy makers, Chiesi

By Dan Stanton

The shelf life of a cell therapy product is crucial in determining a firm’s manufacturing strategy according to the makers of the first approved stem-cell based drug.

Rendering of new 300,000 square foot facility (PRNewsFoto/N.Y. State Executive Chamber)

Athenex to invest $1.62bn in biotech facilities

By Melissa Fassbender

Athenex will invest a minimum of $1.62 bn over the next ten years in labor, materials, and supplies, to create a new manufacturing facility and to expand its North American headquarters.

Follow us